This Socioeconomic session was recorded live at the 2025 AANS Annual Scientific Meeting.
A panel will present up to date information on coding performance of ABNS Oral Board candidates and organized neurosurgery’s current efforts to fill the knowledge gap. Next, a panel will examine the various issues, pros and cons of organized labor in neurosurgery training and practice.
Speakers: Jan-Karl Burkhardt, Amani Carson, Alvin Chan, Pierce Davis, Asimina Dominari, Brian Gantwerker, Hiba Hamid, Grace Ng, Laura Ngwenya, Nnaemeka Nwoke, Akash Patel, Charlotte Pineda, Clemens Schirmer, Husain Shakil, Youssef Sibih, Scott Simon, Michael Tawil, Luis Tumialan, Sarah Woodrow, Omar Zalatimo, Christian Zimmerman
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AANS designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The last date to claim credit is 06/26/2027.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Integrity and Independence in Accredited Education, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.
Those who have disclosed a relationship with ineligible companies are listed below.
All disclosed financial relationships have been mitigated in accordance with ACCME standards.
|
Name
|
Relationship/Company |
| Jan-Karl Burkhardt |
Medtronic Stryker microvention: Consultant (Ongoing); Q`Apel Medical, BALT: Consultant (Ongoing); Siemens: Consultant (Ongoing) |
| Laura Ngwenya |
Abbott: Grant/Research Support (Ongoing); Biogen: Grant/Research Support (Ongoing) |
| Clemens Schirmer |
Balt: Consultant (Ongoing), Research Grant (Ongoing); Cerenovus: Consultant (Ongoing), Research Grant (Ongoing); Medtronic: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); Microvention: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); MIVI Neuroscience: Grant/Research Support (Terminated, August 1, 2024), Research Grant (Terminated, August 1, 2024); NIH/NINDS: Grant/Research Support (Ongoing), Research Grant (Ongoing); NTI: Ownership Interest (Ongoing); Penumbra: Grant/Research Support (Ongoing), Research Grant (Ongoing); Route 92: Grant/Research Support (Terminated, December 31, 2024), Research Grant (Terminated, December 31, 2024); Stryker: Consultant (Ongoing), Grant/Research Support (Ongoing), Research Grant (Ongoing); Viz.ai: Speaker/Honoraria (Ongoing) |
| Omar Zalatimo |
Providence Medical Technology: Consultant (Ongoing), Speaker/Honoraria (Ongoing) |
Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships or conflict of interest to disclose for this activity.